Nobelpharma Company Profile
✉ Email this page to a colleague
What is the competitive landscape for NOBELPHARMA, and what generic and branded alternatives to NOBELPHARMA drugs are available?
NOBELPHARMA has one approved drug.
Drugs and US Patents for Nobelpharma
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Nobelpharma | HYFTOR | sirolimus | GEL;TOPICAL | 213478-001 | Mar 22, 2022 | RX | Yes | Yes | ⤷ Sign Up | ⤷ Sign Up | |||||
Nobelpharma | HYFTOR | sirolimus | GEL;TOPICAL | 213478-001 | Mar 22, 2022 | RX | Yes | Yes | ⤷ Sign Up | ⤷ Sign Up | |||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Similar Applicant Names
Here is a list of applicants with similar names.